These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3925877)

  • 1. In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosa.
    Ng WW; Chau PY; Leung YK; Livermore DM
    Antimicrob Agents Chemother; 1985 May; 27(5):872-3. PubMed ID: 3925877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
    Bremner DA
    J Antimicrob Chemother; 1985 Oct; 16(4):457-61. PubMed ID: 3934129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftazidime and other beta-lactam antibiotics against nosocomial strains of Pseudomonas aeruginosa.
    Santos Ferreira MO; Bacelar MJ; Canica MM
    J Int Med Res; 1984; 12(6):356-60. PubMed ID: 6440822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
    Sofianou DC; Douboyas JP
    J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparison of Pseudomonas aeruginosa isolates with various susceptibilities to aminoglycosides and ten beta-lactam antibiotics.
    Wu DH; Baltch AL; Smith RP
    Antimicrob Agents Chemother; 1984 Apr; 25(4):488-90. PubMed ID: 6428308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
    Oie S; Sawa A; Kamiya A; Mizuno H
    J Antimicrob Chemother; 1999 Nov; 44(5):689-91. PubMed ID: 10552987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of 100 blood isolates of Pseudomonas aeruginosa to 19 antipseudomonal antibiotics: old and new.
    Korvick J; Yu VL; Hilf M
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):107-11. PubMed ID: 3115670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS; Neu HC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies of investigational beta-lactams as possible therapy for Pseudomonas aeruginosa endocarditis.
    Zar FA; Kany RJ
    Antimicrob Agents Chemother; 1985 Jan; 27(1):1-3. PubMed ID: 3920956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of beta-lactam antibiotics against 'intrinsically' ticarcillin-resistant strains of Pseudomonas aeruginosa.
    Bert F; Bruneau B; Lambert-Zechovsky N; Branger C
    Chemotherapy; 1994; 40(3):183-7. PubMed ID: 8205936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
    Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the in-vitro activity of new agents on Pseudomonas aeruginosa isolates from cystic fibrosis patients and other chronic infections.
    Gordts B; Vandenborre C; VanderAuwera P; Butzler JP
    J Antimicrob Chemother; 1984 Jul; 14(1):25-9. PubMed ID: 6434504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients with the clinical use of newer antibiotics.
    Bosso JA; Allen JE; Matsen JM
    Antimicrob Agents Chemother; 1989 Apr; 33(4):526-8. PubMed ID: 2499252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic.
    Angehrn P
    Chemotherapy; 1985; 31(6):440-50. PubMed ID: 3935396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates.
    Humphries RM; Hindler JA; Wong-Beringer A; Miller SA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of antibiotics against resistant Pseudomonas aeruginosa.
    Fujita J; Negayama K; Takigawa K; Yamagishi Y; Kubo A; Yamaji Y; Takahara J
    J Antimicrob Chemother; 1992 May; 29(5):539-46. PubMed ID: 1365010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.